Your browser doesn't support javascript.
loading
A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease.
Wirta, David L; Torkildsen, Gail L; Moreira, Helen R; Lonsdale, John D; Ciolino, Joseph B; Jentsch, Garrit; Beckert, Michael; Ousler, George W; Steven, Philipp; Krösser, Sonja.
Afiliación
  • Wirta DL; Eye Research Foundation, Newport Beach, California.
  • Torkildsen GL; Andover Eye Associates, Andover, Massachusetts.
  • Moreira HR; MedRACS Clinical Research, LLC, Quincy, Massachusetts.
  • Lonsdale JD; Central Maine Eye Care, Lewiston, Maine.
  • Ciolino JB; Massachusetts Eye and Ear Infirmary / Harvard Medical School, Boston, Massachusetts.
  • Jentsch G; BAST Modelling & Simulation Consultancy Service, Heidelberg, Germany.
  • Beckert M; Clinical and Regulatory Affairs Consultancy Services (CaRACS), Berlin, Germany.
  • Ousler GW; Ora Inc, Andover, Massachusetts.
  • Steven P; Department of Ophthalmology, Medical Faculty, University of Cologne, Cologne, Germany.
  • Krösser S; Novaliq GmbH, Heidelberg, Germany. Electronic address: skroesser@novaliq.com.
Ophthalmology ; 126(6): 792-800, 2019 06.
Article en En | MEDLINE | ID: mdl-30703441
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes de Ojo Seco / Ciclosporina / Inmunosupresores Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes de Ojo Seco / Ciclosporina / Inmunosupresores Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article